Quan Anh Vu

Quan Anh Vu

Net worth: 195 802 $ as of 30/04/2024

52 year
9 connections
Health Technology
Consumer Services
Finance

Career history of Quan Anh Vu

Former positions of Quan Anh Vu

CompaniesPositionStartEnd
OCUGEN, INC. Comptroller/Controller/Auditor 10/03/2023 14/08/2023
Director of Finance/CFO 06/03/2023 14/08/2023
Corporate Officer/Principal 01/02/2023 06/03/2023
180 LIFE SCIENCES CORP. Chief Operating Officer 29/10/2021 18/01/2023
Solganick & Co., Inc. Corporate Officer/Principal 01/09/2019 01/10/2021
Baleena Bioscience, Inc. Corporate Officer/Principal 01/04/2021 01/10/2021
OPIANT PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2016 01/08/2019

Training of Quan Anh Vu

University of California, Los Angeles Undergraduate Degree

Statistics

International

United States 6
2

Operational

Corporate Officer/Principal 4
Undergraduate Degree 1
Chief Operating Officer 1

Sectoral

Health Technology 4
Consumer Services 2
Finance 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
180 LIFE SCIENCES CORP.

Health Technology

OCUGEN, INC.

Health Technology

Private companies3
Solganick & Co., Inc.

Finance

Opiant Pharmaceuticals, Inc.
Logo Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

Pharmaceuticals: MajorHealth Technology

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA.

Health Technology

Baleena Bioscience, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Quan Anh Vu
  4. Experience